Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage

Neurosurgery

Volumn 41, Issue 4, 1997, Pages 807-812

  Suzuki, Yoshio ^a   Osuka, Koji ^a   Noda, Atsushi ^a   Tanazawa, Toshihiko ^b   Takayasu, Masakazu ^a   Shibuya, Masato ^a   Yoshida, Jun ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kainan Hospital   (Japan)

Author keywords

Cerebrospinal fluid; Nitric oxide; Nitric oxide metabolites; Nitric oxide synthase; Nitrite nitrate; Subarachnoid hemorrhage

Indexed keywords

METHYLPREDNISOLONE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ADULT; ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; STEROID THERAPY; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; ANEURYSM, RUPTURED; CISTERNA MAGNA; ENZYME INDUCTION; FEMALE; HEMIFACIAL SPASM; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; REFERENCE VALUES; SUBARACHNOID HEMORRHAGE; TRIGEMINAL NEURALGIA; VENTRICULOSTOMY;

EID: 0030821181     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199710000-00008     Document Type: Article

References (38)

1. Borgerding RA, Murphy S: Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes. J Neurochem 65:1342-1347, 1995.
2. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262:10438-10440, 1987.
3. Bredt DS, Snyder SH: Nitric oxide: A novel neural messenger. Neuron 8:3-11, 1992.
4. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90:1161-1121, 1992.
5. Dawson DA: Nitric oxide and focal cerebral ischemia: Multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 6:299-324, 1994.
6. Edwards DH, Byrne JV, Griffith TM: The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 76:830-837, 1992.
7. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computed tomographic scanning. Neurosurgery 6:1-9, 1980.
8. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 26:131-138, 1982.
9. Haley EC, Kassell NF, Alves WM, Weir BKA, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage: A report of the cooperative aneurysm study. J Neurosurg 82:786-790, 1995.
10. Hino A, Tokuyama Y, Weir B, Takeda J, Yano H, Bell GI, Macdonald RL: Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 39:562-568, 1996.
11. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tukahara T, Ogawa H, Vollmer DG, Lehman RM: Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 69:247-253, 1988.
12. Hunt W, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysm. J Neurosurg 28:14-21, 1968.
13. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175-192, 1994.
14. Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K: Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage. J Neurosurg 80:476-483, 1994.
15. Kanamaru K, Weir BKA, Findlay JM, Krueger CA, Cook DA: Pharmacological studies on relaxation of spastic primate cerebral arteries in subarachnoid hemorrhage. J Neurosurg 71:909-915, 1989.
16. Kasuya H, Weir BKA, Nakane M, Pollock JS, Johns L, Marton LS, Stefansson K: Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg 82:250-255, 1995.
17. Katusic ZS, Milde JH, Consentino F, Mitrovic BS: Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke 24:392-399, 1993.
18. Kim P, Sundt TM Jr, Vanhoutte PM: Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg 69:239-246, 1988.
19. Knowles RG, Salter M, Brooks SL, Moncada S: Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 172:1042-1048, 1990.
20. Kubus P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88:4651-4655, 1991.
21. Kumura E, Kosaka H, Shiga T, Yoshimine T, Hayakawa T: Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab 14:487-491, 1994.
22. Kumura E, Yoshimine T, Tanaka S, Hayakawa T, Shiga T, Kosaka H: Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci Lett 177:165-167, 1994.
23. Mathiesen T, Andersson B, Loftenius A, von Holst H: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 78:562-567, 1993.
24. Merrill JE, Benveniste EN: Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci 19:331-338, 1996.
25. Moncada S, Palmer RJM, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1977.
26. Osuka K, Suzuki Y, Saito K, Takayasu M, Shibuya M: Changes in cytokine concentrations after neurosurgical procedures. Acta Neurochir 138:970-978, 1996.
27. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH: Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 84:648-654, 1996.
28. Radomski MW, Palmer RMJ, Moncada S: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482-1489, 1987.
29. Radomski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 87:10043-10047, 1990.
30. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Botelho LHP: Cvtoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 181:1392-1397, 1991.
31. Steinke DE, Weir BKA, Findlay JM, Tanabe T, Grace M, Krushelnycky BW: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24:179-186, 1989.
32. Suzuki S, Kassell NF, Lee KS: Hemin activation of an inducible isoform of nitric oxide synthase in vascular smooth-muscle cells. J Neurosurg 83:862-866, 1995.
33. Suzuki Y, Ogura K, Shibuya M, Okada T, Kageyama N, Yamamoto I, Hara M: Alterations of monoamine metabolites and of tryptophan in the basal cisternal CSF of patients after subarachnoid hemorrhage. Acta Neurochir 87:58-62, 1987.
34. Suzuki Y, Satoh S, Kimura M, Oyama H, Asano T, Shibuya M, Sugita K: Effects of vasopression and oxytocin on canine cerebral circulation in vivo. J Neurosurg 77:424-431, 1992.
35. Suzuki Y, Satoh S, Oyama H, Takayasu M, Shibuya M: Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo. Stroke 24:1049-1054, 1993.
36. Tanazawa T, Suzuki Y, Anzai M, Tsugane S, Takayasu M, Shibuya M: Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid hemorrhage in dogs. Acta Neurochir 138:330-337, 1996.
37. Tsutsui M, Milstien S, Katusic ZS: Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 79:336-342, 1996.
38. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57, 1992.